Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Gastro oesophageal cancer, Oesophageal cancer, Stomach cancer
Closed
Phase 2
This trial is looking at giving more treatment after first treatment for oesophageal cancer and stomach cancer that can’t be removed by surgery. It is open to people with
Cancer where the food pipe meets the stomach (gastro oesophageal junction cancer)
As well as the above, the cancer has spread into the nearby tissue or to another part of the body.
Recruitment start: 1 February 2015
Recruitment end: 7 March 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor David Cunningham
Clovis Oncology Inc
Eli Lilly and Company Limited
Experimental Cancer Medicine Centre (ECMC)
MedImmune LLC (wholly-owned subsidiary of AstraZeneca)
The Royal Marsden NHS Foundation Trust
Last reviewed: 19 March 2024
CRUK internal database number: 11683
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
